Skip to Content

Carlton Fields Intellectual Property Attorney Eleanor M. Yost Named to Top 50 Women in PTAB Trials

Tampa, Fla. – Carlton Fields Shareholder Eleanor M. Yost was named to the Patent Trial and Appeal Board (PTAB) Bar Association’s inaugural Top 50 Women in PTAB Trials list. The list recognizes female practitioners who have appeared in the highest number of U.S. Patent & Trademark Office PTAB trial proceedings since 2012. These leading female practitioners will also be featured in the PTAB Bar Association’s upcoming report on Women at the PTAB, which studies gender diversity at law firms and companies participating in PTAB proceedings.

Yost is an in-demand thought leader on the subject of PTAB post-grant proceedings. She has been featured on the topic in IPLaw360, AmLaw DailyCorporate Counsel, Inside Counsel, The Recorder, Intellectual Property Magazine, Bloomberg BNA, Westlaw Journal Intellectual Property, The Pink Sheet, Managing IP, Lawdragon, and elsewhere.

In her practice she also litigates high-stakes intellectual property disputes in state and federal courts, the U.S. International Trade Commission, and the U.S. Patent and Trademark Office. She manages national and international patent, trademark, and domain name portfolios for some of the most recognizable brands in the world.

Yost is board certified by The Florida Bar in Intellectual Property Law. She earned her J.D. from St. John’s University School of Law and her B.A. from the State University of New York at Stony Brook.


The information on this website is presented as a service for our clients and Internet users and is not intended to be legal advice, nor should you consider it as such. Although we welcome your inquiries, please keep in mind that merely contacting us will not establish an attorney-client relationship between us. Consequently, you should not convey any confidential information to us until a formal attorney-client relationship has been established. Please remember that electronic correspondence on the internet is not secure and that you should not include sensitive or confidential information in messages. With that in mind, we look forward to hearing from you.